“…22 While patients may have been reluctant to admit difficulties if they were uncomfortable with the automated interface of the IVR calls, IVR-obtained health data are at least as reliable as those obtained using structured interview or review of medical records. 7,32 Notwithstanding this fact, follow-up studies should include additional data sources, such as electronic event monitoring, medication refills, or bioassays, in order to validate impacts on patient adherence. A third significant issue was the limited sample size, which may have adversely affected our sensitivity to other effects.…”